- Price
- $88.84
- Day
- -1.58%
- Mkt Cap
- $113.35B
- 52W Range
- $69.51 – $110.68
- Volume
- 21.87M
- Beta
- 0.58
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
CVS Health's Aetna health insurance unit will cut back next year on the preapprovals it requires for treatment for cancer patients to only one medical prior authorization process early on, the company said on Thursday.
Read full article
Oncology bundling to support all eligible Medicaid members for all cancer types Full roll-out across all Aetna businesses in 2027 HARTFORD, Conn., Sept. 17, 2026 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), is expanding prior authorization bundles across all cancer types for members in eligible1 Medicaid states as of September 1, with plans to expand across all lines of business in 2027.
Read full article
CVS trades at a forward multiple that screams cheap, yet the street's already bullish and our model runs even hotter. Before you trust either read, there are a few risks that could turn this setup into a trap.
Read full article
Four winning designs will be featured on limited-edition CVS brand bandages for sale in 2027 WOONSOCKET, R.I., Sept. 16, 2026 /PRNewswire/ -- CVS Health® today announced the launch of its nationwide "Wear Your HeART" Bandage Art Contest, inviting people across the United States to submit original artwork inspired by the importance of protecting personal, family and community health.
Read full article
CVS Health (CVS) concluded the recent trading session at $94.43, signifying a -1.17% move from its prior day's close.
Read full article
CVS Health's Health Services arm is gaining from pharmacy strength and improving care delivery, with robust new sales and clinic economics supporting growth.
Read full article
Bank of America Corp DE grew its stake in CVS Health Corporation (NYSE: CVS) by 148.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,188,670 shares of the pharmacy operator's stock after buying an additional 13,836,701
Read full article
CVS Health recently posted a revenue jump of 7% year over year. Its shares today seem reasonably valued -- or a bit undervalued.
Read full article
RFG Advisory LLC trimmed its position in CVS Health Corporation (NYSE: CVS) by 49.9% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,525 shares of the pharmacy operator's stock after selling 9,471 shares during the quarter. RFG
Read full article
Baird Financial Group Inc. grew its holdings in shares of CVS Health Corporation (NYSE: CVS) by 4.0% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 261,756 shares of the pharmacy operator's stock after buying an additional 10,059 shares during
Read full article
CVS Health trades at a discounted 12x forward P/E versus peers, despite robust business momentum and integrated healthcare assets. Q2 2026 saw 7% YoY revenue growth to $106B and 35% adjusted operating income growth, signaling a turnaround in earnings power. Aetna margin restoration, specialty pharmacy growth, and GLP-1 expansion offset risks from elevated medical costs and regulatory headwinds.
Read full article
CVS Health Corporation (CVS) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Read full article